Stocks to Sell

Stocks can plunge for any number of reasons — investors may need to raise cash for large milestone purchases, or algorithms could be triggered by stop losses which create massive selloffs. Whatever the case, InvestorPlace’s journalists weed out the markets’ losers, keeping you informed of which stocks to cash out of before they come crashing down.

The Math Simply Doesn’t Favor Ocugen Stock

By InvestorPlace Research Staff
Because of the dynamics of the new normal, troubled names like OCGN stock continue to attract speculative interest. Perhaps some math will finally dissuade these gamblers?

Occidental Petroleum Carries Too Much Internal Baggage

By Josh Enomoto, InvestorPlace Contributor
Even the best oil companies are gasping for air in this environment. With a litany of problems weighing on OXY stock beyond oil prices, this might be a name to avoid.

As Shares Pull Back, It’s Time to Sell Vroom

By Thomas Niel, InvestorPlace Contributor
The new normal in auto sales was a boon for e-commerce play Vroom stock, but the easy money has been made. Sell now, as shares cool off.

Momentum Trading Will Not Save Whiting Petroleum From Decline

By Faizan Farooque, InvestorPlace Contributor
WLL stock remains a precarious investment. Bondholders will conservatively guide the company's recovery, so don't expect any miracles soon.

Long-Term Investors May Want To Keep Away From Taoping Stock

By Tezcan Gecgil, InvestorPlace Contributor
Taoping stock's most recent filings highlight major concerns about the company's future. TAOP stock is one to avoid for now.

Turn Out the Lights on iBio’s Covid-19 Vaccine Party

By Todd Shriber, InvestorPlace Contributor
IBIO stock is delivering heartache and more could be on the way as markets realize the company isn't going to deliver a Covid-19 vaccine.

Marathon Patent Group Is Still a No-Go Despite Recent PR Claims

By Alex Sirois, InvestorPlace Contributor
Thinking of picking up MARA stock? Wait to see if its latest move to expand its crypto mining starts to pan out before making your decision.

Continue to Stay Away From Genius Brands Stock

By Luke Lango, InvestorPlace Senior Investment Analyst
GNUS stock is just another pump-and-dump penny stock that's not worth your time or hard-earned money. Stay away from this one.

Like Spoiled Coffee Creamer, Luckin Stock Isn’t Getting Any Better

By Larry Sullivan, InvestorPlace contributor
While some investors are drawn to Luckin stock despite the company’s history of fraud, ignore the cheap price and consider a worthy stock instead.

5 Hot Tech Stocks That Are Caught in a Bubble

By Luke Lango, InvestorPlace Senior Investment Analyst
Wall Street is concerned that we have entered a tech stock bubble. Broadly, we haven't. But these five tech stocks are in bubble territory.

Whiting Petroleum Stock Looks Even Worse After Coming Out of Bankruptcy

By Will Ashworth, InvestorPlace Contributor
Whiting Petroleum emerged from bankruptcy Sep. 1. Shareholders got one share of new WLL stock for 75 of the old. At $19, it’s still not a buy.   

Inovio Stock Is a Longshot Covid-19 Bet

By Ian Bezek, InvestorPlace Contributor
Numerous well-funded coronavirus vaccines are rapidly proceeding through clinical trials. INO stock risks being left behind.

Advanced Micro Devices: Great Company, Overvalued Stock

By Dana Blankenhorn, InvestorPlace Contributor
Dr. Lisa Su has done an incredible job for AMD shareholders since becoming CEO in 2014, but you don't have a profit until you sell and have the cash in your pocket.

The Math Doesn’t Work for Electrameccanica Vehicles

By InvestorPlace Research Staff
With electric vehicle investments representing one of the hottest sectors on Wall Street, you might be tempted to buy SOLO stock. But this is merely a pretender, not a contender.

If You Got Delta Airlines Stock in the Northwest Merger, Dump It Now

By Will Ashworth, InvestorPlace Contributor
The anniversary of the merger between Northwest Airlines and Delta Air Lines is at the end of October. How did owners of DAL stock make out?  

iBio Is Now Lagging in Another Area

By Larry Ramer, InvestorPlace Contributor
iBio's leading vaccine and its therapy appear to be too far behind the competition to generate much revenue for IBIO stock.

The Zoom Stock Bubble Is Getting Out of Control

By Luke Lango, InvestorPlace Senior Investment Analyst
Zoom is on fire, but ZM stock is in a bubble. This reality makes Zoom stock a dangerous play on both the long and short sides.

Identity Crisis Is Hurting XSPA Stock

By Joel Baglole, InvestorPlace Contributor
XPresSpa is having an identity crisis that is impacting its stock price. Investors should avoid this penny stock until the company figures out a sustainable long-term business plan and decides if it will run airport spas or disease testing and vaccination centers going forward. Until then, buying shares of XSPA is too risky and speculative.

Spartan Energy Shows Promise, But It Isn’t a Buy Yet

By Muslim Farooque, InvestorPlace Contributor
SPAQ stock has a lot of potential, but the company needs to finalize an outsourcing deal before investors can take it seriously.
Load More Articles